Lars E. Larsson - Concepedia

Author

Lars E. Larsson

AstraZeneca (Sweden)

Also Known As

LARS E. LARSSON, Lars E Larsson, Lars E. Larsson, Lars Eric Larsson

Publications

573

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)Sahlgrenska University Hospital University of Gothenburg Vanderbilt University Sachs' Children and Youth Hospital

About

Lars E. Larsson is an author at AstraZeneca (Sweden) specializing in medicine, cardiology, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	223
2	Education	1	1	50
3	Health Sciences	1	1	10
4	Natural Sciences	1	1	26
5	Biochemistry	1	1	26

Lars E. Larsson

Publications

563

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants Adrian Bösenberg, Jenny Thomas, L Cronjé, Pediatric Anesthesia	2005	123
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block Hans‐Jürgen Rapp, Valéria Molnár, Stephen M. Austin, Pediatric Anesthesia	2004	74
Pharmacokinetics and analgesic effect of ropivacaine following ilioinguinal/iliohypogastric nerve block in children B Dalens, Claude Ecoffey, Agnès Joly, Pediatric Anesthesia	2001	70
Radial arterial catheters in children and neonates HANS SELLDEAN, Krister Nilsson, Lars E. Larsson, Critical Care Medicine NeonatologyArterial CathetersPediatric Heart DiseaseMedicinePatient Safety	1987	60
Pulmonary Hemodynamic and Ultrastructural Changes Associated with Group B Streptococcal Toxemia in Adult Sheep and Newborn Lambs Jorge Rojas, Lars E. Larsson, Carl G. Hellerqvist, Pediatric Research Animal PhysiologyVeterinary PhysiologyAnimal SciencePhysiologyVeterinary Pathology	1983	50
Effects of Cyclooxygenase Inhibition on the Response to Group B Streptococcal Toxin in Sheep Jorge Rojas, Lars E. Larsson, Martin L. Ogletree, Pediatric Research Microbial ToxinCyclooxygenase InhibitionAntimicrobial SusceptibilityToxinologyMedicine	1983	42
Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system Eva C. Jensen, Svenerik Andréasson, Anders Bengtsson, The Annals of Thoracic Surgery ThrombosisCardiothoracic SurgeryPediatric Heart SurgeryHematologyHemostasis	2004	34
Effects of left-to-right ductus shunting on left ventricular output and cerebral blood flow velocity in 3-day-old preterm infants with and without severe lung disease Mats Mellander, Lars E. Larsson The Journal of Pediatrics NeonatologyPulmonary CirculationLeft-to-right DuctusPediatricsPediatric Lung Disease	1988	32
Synthesis of O-alkylated lysine-vasopressin, inhibitors of the antidiuretic response to lysine-vasopressin Lars E. Larsson, Gunnar Lindeberg, Per Melin, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryClear-cut AntagonismPharmaceutical ScienceBiochemistry	1978	26
VTCO2 and dynamic compliance-guided lung recruitment in surfactant-depleted piglets: A computed tomography study Angela J. Hanson, Sylvia Göthberg, Krister Nilsson, Pediatric Critical Care Medicine	2009	23

Page 1